<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="b20f6f5b-5d06-4912-a401-b38673c0c6c3"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>These highlights do not include all the information needed to use DEXTENZA safely and effectively. See full prescribing information for DEXTENZA.<br/>
      <br/>DEXTENZA<sup>Â®</sup> (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use<br/>Initial U.S. Approval: 1958
</title>
   <effectiveTime value="20250418"/>
   <setId root="7514e6b8-c33f-4fbf-8810-ef520e1eb4bd"/>
   <versionNumber value="17"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="063391985" root="1.3.6.1.4.1.519.1"/>
            <name>Ocular Therapeutix, Inc.
</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="117383794" root="1.3.6.1.4.1.519.1"/>
                        <name>Isomedix Operations, Steris Corporation</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C84382" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="STERILIZE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="70382-204" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="080122594" root="1.3.6.1.4.1.519.1"/>
                        <name>Ocular Therapeutix, Inc.</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="70382-204" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="078525133" root="1.3.6.1.4.1.519.1"/>
                        <name>Packaging Coordinators, Inc.</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C84732" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="LABEL"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="70382-204" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84731" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="PACK"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="70382-204" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="618054084" root="1.3.6.1.4.1.519.1"/>
                        <name>Pharmacia &amp; Upjohn Company LLC</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C82401" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="API MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="70382-204" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section ID="dcl-dpl">
               <id root="32c95435-ae23-4aa7-827d-50e4049e5adc"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL PRODUCT DATA ELEMENTS SECTION"/>
               <effectiveTime value="20250418"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="70382-204" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>DEXTENZA
</name>
                        <formCode code="C60933" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INSERT"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>dexamethasone</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator value="0.4" unit="mg"/>
                              <denominator value="1" unit="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="7S5I7G3JQL" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>dexamethasone
</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="7S5I7G3JQL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>dexamethasone</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="3WJQ0SDW1A" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POLYETHYLENE GLYCOL, UNSPECIFIED</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="Y7F82M80K8" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>LYSYLLYSYLLYSINE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="TPY09G7XIR" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>FLUORESCEIN</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="22ADO53M6F" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM PHOSPHATE, DIBASIC, ANHYDROUS</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="KH7I04HPUU" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="1" unit="1"/>
                              <denominator value="1" unit="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="70382-204-88" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43200" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="POUCH"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1" unit="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="70382-204-01" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43179" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOX, UNIT-DOSE"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20190107"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV" displayName="Type 0: Not a Combination Product"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator value="1" unit="1"/>
                              <denominator value="1" unit="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="70382-204-88" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43200" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="POUCH"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="10" unit="1"/>
                                    <denominator value="1" unit="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="70382-204-10" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43179" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOX, UNIT-DOSE"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20190107"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV" displayName="Type 0: Not a Combination Product"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator value="1" unit="1"/>
                              <denominator value="1" unit="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="70382-204-88" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43200" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="POUCH"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1" unit="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="70382-204-99" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43179" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOX, UNIT-DOSE"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20190107"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV" displayName="Type 0: Not a Combination Product"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <characteristic classCode="OBS">
                           <code code="SPLCOLOR" codeSystem="2.16.840.1.113883.1.11.19255"/>
                           <value xsi:type="CE" code="C48330" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="yellow">
                              <originalText>yellow</originalText>
                           </value>
                        </characteristic>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20190107"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <subjectOf>
                        <approval>
                           <id extension="NDA208742" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38287" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OPHTHALMIC"/>
                        </substanceAdministration>
                     </consumedIn>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C132737" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRACANALICULAR"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="s1">
               <id root="7ef2aa1b-db04-40a2-9fbd-021fb982bea0"/>
               <code code="43683-2" codeSystem="2.16.840.1.113883.6.1" displayName="RECENT MAJOR CHANGES SECTION"/>
               <effectiveTime value="20250418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <table width="100%" styleCode="Noautorules">
                           <col width="80.000%" align="left"/>
                           <col width="20.000%" align="left"/>
                           <tbody>
                              <tr>
                                 <td align="left" valign="top">Indications and Usage (<linkHtml href="#s3">1.1</linkHtml>, <linkHtml href="#s4">1.2</linkHtml>)
</td>
                                 <td align="right" valign="top">04/2025
</td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="s2">
               <id root="602f9497-946f-436e-9d4d-11993ebfc489"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>1 INDICATIONS AND USAGE
</title>
               <effectiveTime value="20250418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>DEXTENZA<sup>Â®</sup> is a corticosteroid indicated for:
</paragraph>
                        <list listType="unordered" styleCode="Disc">
                           <item>The treatment of ocular inflammation and pain following ophthalmic surgery in adults and pediatric patients. (<linkHtml href="#s3">1.1</linkHtml>).
</item>
                           <item>The treatment of ocular itching associated with allergic conjunctivitis in adults and pediatric patients aged 2 years and older. The use of DEXTENZA is not recommended for the treatment of ocular itching associated with allergic conjunctivitis in pediatric patients who require sedation for the insertion procedure. (<linkHtml href="#s4">1.2</linkHtml>).
</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="s3">
                     <id root="12dba9a5-21dc-41af-8305-01eaaefe3b4c"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>1.1 Ocular Inflammation and Pain Following Ophthalmic Surgery
</title>
                     <text>
                        <paragraph>
                           <content styleCode="xmChange"/>DEXTENZA is indicated for the treatment of ocular inflammation and pain following ophthalmic surgery (<linkHtml href="#s3">1.1</linkHtml>).
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="s4">
                     <id root="27fe3536-9220-4ddf-9acc-e4eab4e576be"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>
                        <content styleCode="xmChange"/>1.2 Itching Associated with Allergic Conjunctivitis
</title>
                     <text>
                        <paragraph>
                           <content styleCode="xmChange"/>DEXTENZA is indicated for the treatment of ocular itching associated with allergic conjunctivitis in adults and pediatric patients aged 2 years and older (<linkHtml href="#s4">1.2</linkHtml>).
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="e4">
                     <id root="26049f71-e0fc-464c-868d-b44fcfd547e8"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="xmChange"/>
                           <content styleCode="underline">Limitations of Use</content>
                        </paragraph>
                        <paragraph>
                           <content styleCode="xmChange"/>The use of DEXTENZA is not recommended for the treatment of ocular itching associated with allergic conjunctivitis in pediatric patients who require sedation for the insertion procedure <content styleCode="italics">[see Use in Specific Populations (<linkHtml href="#s26">8.4</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s5">
               <id root="d55c107e-c4a7-4909-a080-f673cda357f2"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>2 DOSAGE AND ADMINISTRATION
</title>
               <effectiveTime value="20250418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>DEXTENZA is an ophthalmic insert that is inserted in the lower lacrimal punctum and into the canaliculus. A single DEXTENZA releases a 0.4 mg dose of dexamethasone for up to 30 days following insertion (<linkHtml href="#s5">2</linkHtml>).
</paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="s6">
                     <id root="035f5525-4e43-4a1d-93b3-0d724d352bba"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.1 General Dosing Information
</title>
                     <text>
                        <paragraph>DEXTENZA is an ophthalmic insert that is inserted in the lower lacrimal punctum into the canaliculus. A single DEXTENZA insert releases a 0.4 mg dose of dexamethasone for up to 30 days following insertion.
</paragraph>
                        <paragraph>DEXTENZA is resorbable and does not require removal. Saline irrigation or manual expression can be performed to remove the insert if necessary. DEXTENZA is intended for single-use only.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="s7">
                     <id root="69b28089-a4d7-420f-b856-6adfd88946ed"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.2 Administration
</title>
                     <text>
                        <paragraph>Do not use if pouch has been damaged or opened. Do not re-sterilize.
</paragraph>
                        <list listType="ordered" styleCode="Arabic">
                           <item>Carefully remove foam carrier and transfer to a clean and dry area.
</item>
                           <item>If necessary, dilate the punctum with an ophthalmic dilator. Care should be taken not to perforate the canaliculus during dilation or insertion of DEXTENZA. If perforation occurs, do not insert DEXTENZA.
</item>
                           <item>After drying the punctal area, using blunt (non-toothed) forceps, grasp DEXTENZA and insert into the lower lacrimal canaliculus by pulling the lid temporally and inserting nasally.
</item>
                           <item>Ensure DEXTENZA is placed just below the punctal opening. Excessive squeezing of DEXTENZA with forceps may cause deformation.
</item>
                           <item>To aid in the hydration of DEXTENZA, 1 to 2 drops of balanced salt solution can be instilled into the punctum. DEXTENZA hydrates quickly upon contact with moisture. If DEXTENZA begins to hydrate before fully inserted, discard the product and use a new DEXTENZA.
</item>
                           <item>DEXTENZA can be visualized when illuminated by a blue light source (e.g., slit lamp or hand held blue light) with yellow filter.
</item>
                        </list>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s8">
               <id root="5dab7bf5-d48e-4090-b753-a16ef1717c68"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
               <title>3 DOSAGE FORMS AND STRENGTHS
</title>
               <text>
                  <paragraph>Ophthalmic insert: fluorescent yellow, 3 mm cylindrical-shaped insert containing dexamethasone, 0.4 mg.
</paragraph>
               </text>
               <effectiveTime value="20250418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Ophthalmic intracanalicular insert containing a 0.4 mg dose of dexamethasone (<linkHtml href="#s8">3</linkHtml>).
</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="s9">
               <id root="3d23a6eb-6547-42b1-998c-ddb709fd9187"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>4 CONTRAINDICATIONS
</title>
               <text>
                  <paragraph>DEXTENZA is contraindicated in patients with active corneal, conjunctival or canalicular infections, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella; mycobacterial infections; fungal diseases of the eye, and dacryocystitis.
</paragraph>
               </text>
               <effectiveTime value="20250418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Active ocular infections (<linkHtml href="#s9">4</linkHtml>).
</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="s10">
               <id root="e67ddfb1-afb5-4e89-b181-391ce25834c6"/>
               <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
               <title>5 WARNINGS AND PRECAUTIONS
</title>
               <effectiveTime value="20250418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>
                              <content styleCode="underline">Intraocular Pressure Increase</content>: Monitor intraocular pressure (<linkHtml href="#s11">5.1</linkHtml>).
</item>
                           <item>
                              <content styleCode="underline">Bacterial Infections</content>: Steroids may mask signs of infections and enhance existing infections (<linkHtml href="#s12">5.2</linkHtml>).
</item>
                           <item>
                              <content styleCode="underline">Viral Infections</content>: Ocular steroids may prolong the course and exacerbate the severity of ocular viral infections (<linkHtml href="#s13">5.3</linkHtml>).
</item>
                           <item>
                              <content styleCode="underline">Fungal Infections</content>: Consider fungal invasion in any persistent corneal ulceration (<linkHtml href="#s14">5.4</linkHtml>).
</item>
                           <item>
                              <content styleCode="underline">Delayed Healing</content>: Ocular steroids may slow the rate of ocular healing. (<linkHtml href="#s15">5.5</linkHtml>).
</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="s11">
                     <id root="209fc38e-529e-4594-a1df-0bd9d348f1db"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.1 Intraocular Pressure Increase
</title>
                     <text>
                        <paragraph>Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision. Steroids should be used with caution in the presence of glaucoma. Intraocular pressure should be monitored during the course of the treatment.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="s12">
                     <id root="5299c816-2566-49fe-89dd-110ff6c9afd0"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.2 Bacterial Infection
</title>
                     <text>
                        <paragraph>Corticosteroids may suppress the host response and thus increase the hazard for secondary ocular infections. In acute purulent conditions, steroids may mask infection and enhance existing infection <content styleCode="italics">[see Contraindications (<linkHtml href="#s9">4</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="s13">
                     <id root="073cc4e6-4fa7-42cc-9772-a4a4aacb7f9e"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.3 Viral Infections
</title>
                     <text>
                        <paragraph>Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex) <content styleCode="italics">[see Contraindications (<linkHtml href="#s9">4</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="s14">
                     <id root="90a6e041-2981-4f4c-8a14-ae5d7ee517f7"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.4 Fungal Infections
</title>
                     <text>
                        <paragraph>Fungus invasion must be considered in any persistent corneal ulceration where a steroid has been used or is in use. Fungal culture should be taken when appropriate <content styleCode="italics">[see Contraindications (<linkHtml href="#s9">4</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="s15">
                     <id root="c8bd6458-8b76-40bc-89de-fdddc63b73d5"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.5 Delayed Healing
</title>
                     <text>
                        <paragraph>The use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="e15">
                     <id root="7bb52d76-1110-4ded-aaff-797e7120c7e6"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.6  Other Potential Corticosteroid Complications
</title>
                     <text>
                        <paragraph>The initial prescription and renewal of the medication order of DEXTENZA should be made by a physician only after examination of the patient with the aid of magnification, such as slit lamp biomicroscopy, and, where appropriate, fluorescein staining. If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s16">
               <id root="13002814-3fb2-4751-8f75-fc77313c7ee9"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>6 ADVERSE REACTIONS
</title>
               <text>
                  <paragraph>The following serious adverse reactions are described elsewhere in the labeling:
</paragraph>
                  <list listType="unordered" styleCode="Disc">
                     <item>Intraocular Pressure Increase <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s11">5.1</linkHtml>)]</content>
                     </item>
                     <item>Bacterial Infection <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s12">5.2</linkHtml>)]</content>
                     </item>
                     <item>Viral Infection <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s13">5.3</linkHtml>)]</content>
                     </item>
                     <item>Fungal Infection <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s14">5.4</linkHtml>)]</content>
                     </item>
                     <item>Delayed Healing <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s15">5.5</linkHtml>)]</content>
                     </item>
                  </list>
               </text>
               <effectiveTime value="20250418"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="Disc">
                           <item>The most commonly reported adverse reactions were anterior chamber inflammation and elevations in intraocular pressure.  These occurred in approximately 6-10% of patients (<linkHtml href="#s16">6</linkHtml>).
</item>
                        </list>
                        <paragraph>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact Ocular Therapeutix at 1-800-DEXTENZA (339-8369) or FDA at 1-800-FDA-1088 or </content>
                           <content styleCode="bold italics">www.fda.gov/medwatch</content>
                           <content styleCode="bold">.</content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="s17">
                     <id root="c382a6a2-2899-44f5-bc72-bcd4c5124e96"/>
                     <code code="90374-0" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL TRIALS EXPERIENCE SECTION"/>
                     <title>6.1 Clinical Trials Experience
</title>
                     <text>
                        <paragraph>Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. Adverse reactions associated with ophthalmic steroids include elevated intraocular pressure, which may be associated with optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation; delayed wound healing; secondary ocular infection from pathogens including herpes simplex, and perforation of the globe where there is thinning of the cornea or sclera <content styleCode="italics">[see Warnings and Precautions (<linkHtml href="#s10">5</linkHtml>)]</content>.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="s18">
                     <id root="d143cd75-36c4-4b9d-ace6-98d583582011"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>6.2 Ocular Inflammation and Pain Following Ophthalmic Surgery
</title>
                     <text>
                        <paragraph>DEXTENZA safety was studied in four randomized, vehicle-controlled studies (n = 567). The mean age of the population was 68 years (range 35 to 87 years), 59% were female, and 83% were white. Forty-seven percent had brown iris color and 30% had blue iris color. The most common ocular adverse reactions that occurred in patients treated with DEXTENZA were: anterior chamber inflammation including iritis and iridocyclitis (10%); intraocular pressure increased (6%); visual acuity reduced (2%); cystoid macular edema (1%); corneal edema (1%); eye pain (1%) and conjunctival hyperemia (1%).
</paragraph>
                        <paragraph>The most common non-ocular adverse reaction that occurred in patients treated with DEXTENZA was headache (1%).
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="s19">
                     <id root="9fb88a9a-3a61-4b95-af70-ad3274a41ebb"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>6.3 Itching  Associated with Allergic Conjunctivitis
</title>
                     <text>
                        <paragraph>DEXTENZA safety was studied in four randomized, vehicle-controlled studies (n= 154).  The mean age of the population was 41 years (range 19 to 69 years), 55 % were female and 61 % were white.  Fifty seven percent had brown iris color and 20% had blue iris color. The most common ocular adverse reactions that occurred in patients treated with DEXTENZA were: intraocular pressure increased (3%), lacrimation increased (1%), eye discharge (1%), and visual acuity reduced (1%).
</paragraph>
                        <paragraph>The most common non-ocular adverse reaction that occurred in patients treated with DEXTENZA was headache (1%).
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s20">
               <id root="a45ca72a-383f-441d-9166-e980e90b1a7a"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
               <title>8 USE IN SPECIFIC POPULATIONS
</title>
               <effectiveTime value="20250418"/>
               <component>
                  <section ID="s21">
                     <id root="53cd2bd2-dac2-4172-9cc3-bdcb12b22f91"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>8.1 Pregnancy
</title>
                     <effectiveTime value="20250418"/>
                     <component>
                        <section ID="s22">
                           <id root="4c74363f-727a-44d7-89f3-f9c6a8a7ef17"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Risk Summary</content>
                              </paragraph>
                              <paragraph>There are no adequate or well-controlled studies with DEXTENZA in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. In animal reproduction studies, administration of topical ocular dexamethasone to pregnant mice and rabbits during organogenesis produced embryofetal lethality, cleft palate and multiple visceral malformations <content styleCode="italics">(see <linkHtml href="#s23">Data</linkHtml>)</content>.
</paragraph>
                           </text>
                           <effectiveTime value="20250418"/>
                        </section>
                     </component>
                     <component>
                        <section ID="s23">
                           <id root="353574b1-71de-4050-a97b-741fb90cd3a8"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <text>
                              <paragraph>
                                 <content styleCode="underline">Data</content>
                              </paragraph>
                           </text>
                           <effectiveTime value="20250418"/>
                           <component>
                              <section ID="s24">
                                 <id root="89203dd7-bba1-4545-8cd6-cba9838ed00b"/>
                                 <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                                 <text>
                                    <paragraph>
                                       <content styleCode="italics">Animal Data</content>
                                    </paragraph>
                                    <paragraph>Topical ocular administration of 0.15% dexamethasone (0.75 mg/kg/day) on gestational days 10 to 13 produced embryofetal lethality and a high incidence of cleft palate in a mouse study. A daily dose of 0.75 mg/kg/day in the mouse is approximately 5 times the entire dose of dexamethasone in the DEXTENZA product, on a mg/m<sup>2</sup> basis. In a rabbit study, topical ocular administration of 0.1%Â dexamethasone throughout organogenesis (0.36 mg /day, on gestational day 6 followed by 0.24 mg/day on gestational days 7-18) produced intestinal anomalies, intestinal aplasia, gastroschisis and hypoplastic kidneys. A daily dose of 0.24 mg/day is approximately 6 times the entire dose of dexamethasone in the DEXTENZA product, on a mg/m<sup>2</sup> basis.
</paragraph>
                                 </text>
                                 <effectiveTime value="20250418"/>
                              </section>
                           </component>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="s25">
                     <id root="f891cf7b-d27b-4e35-9dc9-9d6b7c2bb6a1"/>
                     <code code="77290-5" codeSystem="2.16.840.1.113883.6.1" displayName="LACTATION SECTION"/>
                     <title>8.2 Lactation
</title>
                     <text>
                        <paragraph>Systemically administered corticosteroids appear in human milk and could suppress growth and interfere with endogenous corticosteroid production; however the systemic concentration of dexamethasone following administration of DEXTENZA is low <content styleCode="italics">[see Clinical Pharmacology (<linkHtml href="#s31">12.3</linkHtml>)]</content>. There is no information regarding the presence of DEXTENZA in human milk, the effects of the drug on the breastfed infant or the effects of the drug on milk production to inform risk of DEXTENZA to an infant during lactation. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for DEXTENZA and any potential adverse effects on the breastfed child from DEXTENZA.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="s26">
                     <id root="3a2f8d8d-635a-401a-85f3-a03b07c75326"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>8.4 Pediatric Use
</title>
                     <text>
                        <paragraph>The safety and effectiveness of DEXTENZA for the treatment of ocular inflammation and pain following ophthalmic surgery have been established in pediatric patients.
</paragraph>
                        <paragraph>The safety and effectiveness of DEXTENZA for the treatment of ocular itching associated with allergic conjunctivitis have been established in pediatric patients aged 2 years and older. The use of DEXTENZA is not recommended for the treatment of ocular itching associated with allergic conjunctivitis in pediatric patients who require sedation for the insertion procedure.
</paragraph>
                        <paragraph>Use of DEXTENZA for these indications is supported by evidence from adequate and well-controlled studies in adults with additional safety data from a single active-controlled study in pediatric patients aged birth to 5 years old <content styleCode="italics">[see Clinical Studies (<linkHtml href="#s34">14</linkHtml>)]</content>. A similar safety profile was observed between pediatric and adult patients.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="s27">
                     <id root="5f345768-3c21-4020-8f75-ca986a8876de"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>8.5 Geriatric Use
</title>
                     <text>
                        <paragraph>No overall differences in safety or effectiveness have been observed between elderly and younger patients.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s28">
               <id root="ace1a91f-7ade-4cdf-98a8-75acff4bb11f"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>11 DESCRIPTION
</title>
               <text>
                  <paragraph>DEXTENZA (dexamethasone ophthalmic insert) is a fluorescent yellow, 3 mm cylindrical-shaped, resorbable, sterile insert for intracanalicular use. DEXTENZA contains 0.4 mg dexamethasone in a polyethylene glycol (PEG) based hydrogel conjugated with fluorescein.  DEXTENZA does not contain an antimicrobial preservative. The active ingredient is represented by the chemical structure:
</paragraph>
                  <paragraph>
                     <renderMultiMedia ID="f01" referencedObject="mm01"/>
                  </paragraph>
                  <paragraph>The chemical name for dexamethasone is 9-Fluoro-11Î²,17,21-trihydroxy-16Î±-methylpregna-1,4-diene-3,20-dione. It has a molecular formula of C<sub>22</sub>H<sub>29</sub>FO<sub>5</sub> and a molecular weight of 392.47 g/mol. Dexamethasone is a crystalline powder.
</paragraph>
                  <paragraph>Each DEXTENZA contains: <content styleCode="bold">Active ingredients:</content> 0.4 mg dexamethasone. <content styleCode="bold">Inactive ingredients:</content> 4-arm polyethylene glycol (PEG) N-hydroxysuccinimidyl glutarate (20K), trilysine acetate, N-hydroxysuccinimide-fluorescein, sodium phosphate dibasic, sodium phosphate monobasic, water for injection.
</paragraph>
               </text>
               <effectiveTime value="20250418"/>
               <component>
                  <observationMedia ID="mm01">
                     <text>Chemical Structure
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dex0e-0020-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="s29">
               <id root="4eed8e6c-8c8b-4d7f-b513-711c033529fa"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>12 CLINICAL PHARMACOLOGY
</title>
               <effectiveTime value="20250418"/>
               <component>
                  <section ID="s30">
                     <id root="b70b1e89-d469-4fe1-b903-1079febbb42a"/>
                     <code code="43679-0" codeSystem="2.16.840.1.113883.6.1" displayName="MECHANISM OF ACTION SECTION"/>
                     <title>12.1 Mechanism of Action
</title>
                     <text>
                        <paragraph>Dexamethasone, a corticosteroid, has been shown to suppress inflammation by inhibiting multiple inflammatory cytokines resulting in decreased edema, fibrin deposition, capillary leakage and migration of inflammatory cells.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="s31">
                     <id root="a29b5484-d86a-435b-b8df-535928b4ce2a"/>
                     <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                     <title>12.3 Pharmacokinetics
</title>
                     <text>
                        <paragraph>Plasma samples were obtained from 16 healthy volunteers prior to insertion of DEXTENZA and on Day 1 (at 1, 2, 4, 8, 16 hours), 2 (24 hours), 4, 8, 15, 22 and 29 following the insertion of DEXTENZA.
</paragraph>
                        <paragraph>Plasma concentrations of dexamethasone were detectable (above 50 pg/mL, the lower limit of quantification of the assay) in 11% of samples (21 of 189), and ranged from 0.05 ng/mL to 0.81 ng/mL.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s32">
               <id root="9b90baff-bfd5-4b96-87fd-04d8825777cd"/>
               <code code="43680-8" codeSystem="2.16.840.1.113883.6.1" displayName="NONCLINICAL TOXICOLOGY SECTION"/>
               <title>13 NONCLINICAL TOXICOLOGY
</title>
               <effectiveTime value="20250418"/>
               <component>
                  <section ID="s33">
                     <id root="3dd8c68a-f382-43d7-8d52-641503661a83"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
</title>
                     <text>
                        <paragraph>No adequate studies in animals have been conducted to determine whether DEXTENZA has the potential for carcinogenesis.
</paragraph>
                        <paragraph>Dexamethasone was not mutagenic in the Ames/Salmonella assay, both with and without metabolic activation. Dexamethasone was genotoxic in two <content styleCode="italics">in vitro</content> assays using human lymphocytes (chromosomal aberration assay and sister chromatid exchange assay) and was genotoxic in two mouse <content styleCode="italics">in vivo</content> assays (micronucleus assay and sister chromatid exchange assay).
</paragraph>
                        <paragraph>Fertility studies have not been conducted in animals using DEXTENZA.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s34">
               <id root="91af1873-3a55-4176-873d-b97de3d92910"/>
               <code code="34092-7" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL STUDIES SECTION"/>
               <title>14 CLINICAL STUDIES
</title>
               <effectiveTime value="20250418"/>
               <component>
                  <section ID="s35">
                     <id root="5a4be53e-9fb5-46af-bc3c-479d6c9cd776"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.1 Ocular Inflammation and Pain Following Ophthalmic Surgery
</title>
                     <text>
                        <paragraph>In three randomized, multicenter, double-masked, parallel group, vehicle-controlled efficacy trials, patients received DEXTENZA or its vehicle immediately upon completion of cataract surgery (NCT02034019, NCT02089113, NCT02736175).   In all three trials, DEXTENZA had a higher proportion of patients than the vehicle group who were pain free on post-operative Day 8.  On post-operative Day 14, in two of the three studies, DEXTENZA had a higher proportion of patients than the vehicle group who had an absence of anterior chamber cells that was statistically significant. Results are shown in <linkHtml href="#t1">Table 1</linkHtml> and <linkHtml href="#t2">Table 2</linkHtml>.
</paragraph>
                        <table ID="t1" width="100%">
                           <caption>Table 1: Percentage of Patients with Absence of Anterior Chamber Cells
</caption>
                           <col width="5.883%" align="left"/>
                           <col width="9.849%" align="left"/>
                           <col width="8.424%" align="left"/>
                           <col width="11.549%" align="left"/>
                           <col width="2.150%" align="left"/>
                           <col width="9.849%" align="left"/>
                           <col width="8.424%" align="left"/>
                           <col width="11.332%" align="left"/>
                           <col width="2.150%" align="left"/>
                           <col width="10.057%" align="left"/>
                           <col width="8.783%" align="left"/>
                           <col width="11.549%" align="left"/>
                           <tbody>
                              <tr>
                                 <td align="center" valign="middle" styleCode="Toprule Botrule Lrule"/>
                                 <td colspan="3" align="center" valign="middle" styleCode="Toprule Botrule Rrule">
                                    <content styleCode="bold">Study 1</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Toprule Botrule"/>
                                 <td colspan="3" align="center" valign="middle" styleCode="Toprule Botrule Rrule">
                                    <content styleCode="bold">Study 2</content>
                                 </td>
                                 <td align="center" valign="top" styleCode="Toprule Botrule"/>
                                 <td colspan="3" align="center" valign="top" styleCode="Toprule Botrule Rrule">
                                    <content styleCode="bold">Study 3</content>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" valign="middle" styleCode="Lrule Rrule"/>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">dextenza</content>
                                    <br/>
                                    <content styleCode="bold">(N=164)</content>
                                 </td>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Vehicle</content>
                                    <br/>
                                    <content styleCode="bold">(N=83)</content>
                                 </td>
                                 <td rowspan="2" align="center" valign="middle" styleCode="Botrule Rrule">
                                    <content styleCode="bold">Difference</content>
                                    <br/>
                                    <content styleCode="bold">(95% CI)</content>
                                 </td>
                                 <td align="center" valign="middle"/>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">dextenza</content>
                                    <br/>
                                    <content styleCode="bold">(N=161)</content>
                                 </td>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Vehicle</content>
                                    <br/>
                                    <content styleCode="bold">(N=80)</content>
                                 </td>
                                 <td rowspan="2" align="center" valign="middle" styleCode="Botrule Rrule">
                                    <content styleCode="bold">Difference</content>
                                    <br/>
                                    <content styleCode="bold">(95% CI)</content>
                                 </td>
                                 <td align="center" valign="top"/>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Dextenza</content>
                                    <br/>
                                    <content styleCode="bold">(N=216)</content>
                                 </td>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Vehicle</content>
                                    <br/>
                                    <content styleCode="bold">(N=222)</content>
                                 </td>
                                 <td rowspan="2" align="center" valign="middle" styleCode="Botrule Rrule">
                                    <content styleCode="bold">Difference</content>
                                    <br/>
                                    <content styleCode="bold">(95% CI)</content>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" valign="middle" styleCode="Botrule Lrule Rrule">
                                    <content styleCode="bold">Visit</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Botrule">
                                    <content styleCode="bold">n (%)</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Botrule">
                                    <content styleCode="bold">n (%)</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Botrule"/>
                                 <td align="center" valign="middle" styleCode="Botrule">
                                    <content styleCode="bold">n (%)</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Botrule">
                                    <content styleCode="bold">n (%)</content>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule"/>
                                 <td align="center" valign="top" styleCode="Botrule">
                                    <content styleCode="bold">n (%)</content>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule">
                                    <content styleCode="bold">n (%)</content>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" valign="middle" styleCode="Botrule Lrule Rrule">
                                    <content styleCode="bold">Day 14</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Botrule">54 (33%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule">12 (14%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">18% (8%, 29%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule"/>
                                 <td align="center" valign="middle" styleCode="Botrule">63 (39%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule">25 (31%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">8% (-5%, 21%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule"/>
                                 <td align="center" valign="middle" styleCode="Botrule">113 (52%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule">69 (31%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">21 % (12%, 30%)
</td>
                              </tr>
                           </tbody>
                        </table>
                        <table ID="t2" width="100%">
                           <caption>Table 2: Percentage of Patients with Absence of Pain
</caption>
                           <col width="5.868%" align="left"/>
                           <col width="10.060%" align="left"/>
                           <col width="8.426%" align="left"/>
                           <col width="11.402%" align="left"/>
                           <col width="2.275%" align="left"/>
                           <col width="10.060%" align="left"/>
                           <col width="8.426%" align="left"/>
                           <col width="11.377%" align="left"/>
                           <col width="2.100%" align="left"/>
                           <col width="10.060%" align="left"/>
                           <col width="8.693%" align="left"/>
                           <col width="11.252%" align="left"/>
                           <tbody>
                              <tr>
                                 <td align="center" valign="middle" styleCode="Toprule Botrule Lrule"/>
                                 <td colspan="3" align="center" valign="middle" styleCode="Toprule Botrule Rrule">
                                    <content styleCode="bold">Study 1</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Toprule Botrule"/>
                                 <td colspan="3" align="center" valign="middle" styleCode="Toprule Botrule Rrule">
                                    <content styleCode="bold">Study 2</content>
                                 </td>
                                 <td align="center" valign="top" styleCode="Toprule Botrule"/>
                                 <td colspan="3" align="center" valign="top" styleCode="Toprule Botrule Rrule">
                                    <content styleCode="bold">Study 3</content>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" valign="middle" styleCode="Lrule"/>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Dextenza</content>
                                    <br/>
                                    <content styleCode="bold">(N=164)</content>
                                 </td>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Vehicle</content>
                                    <br/>
                                    <content styleCode="bold">(N=83)</content>
                                 </td>
                                 <td rowspan="2" align="center" valign="middle" styleCode="Botrule Rrule">
                                    <content styleCode="bold">Difference</content>
                                    <br/>
                                    <content styleCode="bold">(95% CI)</content>
                                 </td>
                                 <td align="center" valign="middle"/>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Dextenza</content>
                                    <br/>
                                    <content styleCode="bold">(N=161)</content>
                                 </td>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Vehicle</content>
                                    <br/>
                                    <content styleCode="bold">(N=80)</content>
                                 </td>
                                 <td rowspan="2" align="center" valign="middle" styleCode="Botrule Rrule">
                                    <content styleCode="bold">Difference</content>
                                    <br/>
                                    <content styleCode="bold">(95% CI)</content>
                                 </td>
                                 <td align="center" valign="middle"/>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Dextenza</content>
                                    <br/>
                                    <content styleCode="bold">(N=216)</content>
                                 </td>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Vehicle</content>
                                    <br/>
                                    <content styleCode="bold">(N=222)</content>
                                 </td>
                                 <td rowspan="2" align="center" valign="middle" styleCode="Botrule Rrule">
                                    <content styleCode="bold">Difference</content>
                                    <br/>
                                    <content styleCode="bold">(95% CI)</content>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" valign="middle" styleCode="Botrule Lrule">
                                    <content styleCode="bold">Visit</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Botrule">
                                    <content styleCode="bold">n (%)</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Botrule">
                                    <content styleCode="bold">n (%)</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Botrule"/>
                                 <td align="center" valign="middle" styleCode="Botrule">
                                    <content styleCode="bold">n (%)</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Botrule">
                                    <content styleCode="bold">n (%)</content>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule"/>
                                 <td align="center" valign="top" styleCode="Botrule">
                                    <content styleCode="bold">n (%)</content>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule">
                                    <content styleCode="bold">n (%)</content>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" valign="middle" styleCode="Botrule Lrule">
                                    <content styleCode="bold">Day 8</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Botrule">131 (80%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule">36 (43%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">37% (24%, 49%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule"/>
                                 <td align="center" valign="middle" styleCode="Botrule">124 (77%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule">47 (59%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">18% (6%, 31%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule"/>
                                 <td align="center" valign="middle" styleCode="Botrule">172 (80%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule">136 (61%)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">18% (10%, 27%)
</td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
               <component>
                  <section ID="s36">
                     <id root="082ed81d-fa1d-42b4-be9d-335117818540"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>14.2 Itching associated with Allergic Conjunctivitis
</title>
                     <text>
                        <paragraph>In three randomized, multicenter, double-masked, parallel group, vehicle-controlled efficacy trials, patients received DEXTENZA or its vehicle utilizing a repeat conjunctival allergen challenge model (NCT02445326, NCT02988882, NCT04050865).  In all three trials, DEXTENZA resulted in lower mean ocular itching scores compared with the vehicle group at all time points throughout the one-month duration of the study. In two of the three studies, a higher proportion of patients had statistically significant reductions in ocular itching on Day 8, at 3 minutes, 5 minutes and 7 minutes post-challenge in the DEXTENZA group than in the vehicle group.  Results are shown in <linkHtml href="#t3">Table 3</linkHtml>.
</paragraph>
                        <table ID="t3" width="100%">
                           <caption>Table 3: Reduction in Ocular Itching
</caption>
                           <col width="6.570%" align="left"/>
                           <col width="6.616%" align="left"/>
                           <col width="9.093%" align="left"/>
                           <col width="6.616%" align="left"/>
                           <col width="12.924%" align="left"/>
                           <col width="2.192%" align="left"/>
                           <col width="7.831%" align="left"/>
                           <col width="6.200%" align="left"/>
                           <col width="12.193%" align="left"/>
                           <col width="2.477%" align="left"/>
                           <col width="8.270%" align="left"/>
                           <col width="6.616%" align="left"/>
                           <col width="12.401%" align="left"/>
                           <tbody>
                              <tr>
                                 <td align="center" valign="middle" styleCode="Toprule Botrule Lrule"/>
                                 <td align="center" valign="top" styleCode="Toprule Botrule"/>
                                 <td colspan="3" align="center" valign="middle" styleCode="Toprule Botrule Rrule">
                                    <content styleCode="bold">Study 1</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Toprule Botrule"/>
                                 <td colspan="3" align="center" valign="middle" styleCode="Toprule Botrule Rrule">
                                    <content styleCode="bold">Study 2</content>
                                 </td>
                                 <td align="center" valign="top" styleCode="Toprule Botrule"/>
                                 <td colspan="3" align="center" valign="top" styleCode="Toprule Botrule Rrule">
                                    <content styleCode="bold">Study 3</content>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" valign="middle" styleCode="Lrule"/>
                                 <td align="center" valign="top"/>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Dextenza</content>
                                    <br/>
                                    <content styleCode="bold">(N=35)</content>
                                 </td>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Vehicle</content>
                                    <br/>
                                    <content styleCode="bold">(N=38)</content>
                                 </td>
                                 <td rowspan="2" align="center" valign="middle" styleCode="Botrule Rrule">
                                    <content styleCode="bold">Difference</content>
                                    <br/>
                                    <content styleCode="bold">(95% CI)</content>
                                 </td>
                                 <td align="center" valign="middle"/>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Dextenza</content>
                                    <br/>
                                    <content styleCode="bold">(N=44)</content>
                                 </td>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Vehicle</content>
                                    <br/>
                                    <content styleCode="bold">(N=42)</content>
                                 </td>
                                 <td rowspan="2" align="center" valign="middle" styleCode="Botrule Rrule">
                                    <content styleCode="bold">Difference</content>
                                    <br/>
                                    <content styleCode="bold">(95% CI)</content>
                                    <br/>
                                 </td>
                                 <td align="center" valign="middle"/>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Dextenza</content>
                                    <br/>
                                    <content styleCode="bold">(N=48)</content>
                                 </td>
                                 <td align="center" valign="middle">
                                    <content styleCode="bold">Vehicle</content>
                                    <br/>
                                    <content styleCode="bold">(N=48)</content>
                                 </td>
                                 <td rowspan="2" align="center" valign="middle" styleCode="Botrule Rrule">
                                    <content styleCode="bold">Difference</content>
                                    <br/>
                                    <content styleCode="bold">(95% CI)</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr>
                                 <td align="center" valign="middle" styleCode="Botrule Lrule">
                                    <content styleCode="bold">Visit</content>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule">
                                    <content styleCode="bold">Time Point</content>
                                 </td>
                                 <td colspan="2" align="center" valign="middle" styleCode="Botrule">
                                    <content styleCode="bold">Least Square Means</content>
                                 </td>
                                 <td align="center" valign="middle" styleCode="Botrule"/>
                                 <td colspan="2" align="center" valign="middle" styleCode="Botrule">
                                    <content styleCode="bold">Least Square Means</content>
                                 </td>
                                 <td align="center" valign="top" styleCode="Botrule"/>
                                 <td colspan="2" align="center" valign="middle" styleCode="Botrule">
                                    <content styleCode="bold">Least Square Means</content>
                                 </td>
                              </tr>
                              <tr>
                                 <td rowspan="3" align="center" valign="middle" styleCode="Botrule Lrule">
                                    <content styleCode="bold">Day 8</content>
                                 </td>
                                 <td align="center" valign="top">3 min
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">1.9
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">2.7
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">-0.7 (-1.2, -0.3)
</td>
                                 <td align="center" valign="middle" styleCode="Rrule"/>
                                 <td align="center" valign="middle" styleCode="Rrule">2.1
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">2.3
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">-0.2 (-0.7, 0.3)
</td>
                                 <td align="center" valign="middle" styleCode="Rrule"/>
                                 <td align="center" valign="middle" styleCode="Rrule">1.8
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">2.7
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">-0.9 (-1.2, -0.4)
</td>
                              </tr>
                              <tr>
                                 <td align="center" valign="top">5 min
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">2.1
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">2.8
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">-0.7 (-1.2, -0.3)
</td>
                                 <td align="center" valign="middle" styleCode="Rrule"/>
                                 <td align="center" valign="middle" styleCode="Rrule">2.1
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">2.3
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">-0.2 (-0.8, 0.3)
</td>
                                 <td align="center" valign="middle" styleCode="Rrule"/>
                                 <td align="center" valign="middle" styleCode="Rrule">1.8
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">2.7
</td>
                                 <td align="center" valign="middle" styleCode="Rrule">-1.0 (-1.4, -0.6)
</td>
                              </tr>
                              <tr>
                                 <td align="center" valign="top" styleCode="Botrule">7 min
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">1.9
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">2.7
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">-0.8 (-1.2, -0.4)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule"/>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">2.1
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">2.4
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">-0.3 (-0.8, 0.3)
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule"/>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">1.7
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">2.7
</td>
                                 <td align="center" valign="middle" styleCode="Botrule Rrule">-1.0 (-1.4, -0.6)
</td>
                              </tr>
                           </tbody>
                        </table>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s37">
               <id root="2bf5a97b-9f9d-4ff6-b54b-b7950ba7cc81"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>16 HOW SUPPLIED/STORAGE AND HANDLING
</title>
               <text>
                  <paragraph>DEXTENZA is supplied sterile in a foam carrier within a foil laminate pouch containing:
</paragraph>
                  <table width="100%">
                     <col width="27.100%" align="left"/>
                     <col width="72.900%" align="left"/>
                     <tbody>
                        <tr>
                           <td align="left" valign="top">NDC 70382-204-10
</td>
                           <td align="left" valign="top">Carton containing 10 pouches (10 inserts)
</td>
                        </tr>
                        <tr>
                           <td align="left" valign="top">NDC 70382-204-01
</td>
                           <td align="left" valign="top">Carton containing 1 pouch (1 insert)
</td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph>Do not use if pouch has been damaged or broken.
</paragraph>
                  <paragraph>DEXTENZA is intended for single dose only.
</paragraph>
               </text>
               <effectiveTime value="20250418"/>
               <component>
                  <section ID="s38">
                     <id root="347fcec3-8166-4e2f-aff9-25f678eb3ebb"/>
                     <code code="44425-7" codeSystem="2.16.840.1.113883.6.1" displayName="STORAGE AND HANDLING SECTION"/>
                     <text>
                        <paragraph>
                           <content styleCode="bold">Storage:</content> Store refrigerated, between 2Â°C and 8Â°C (36Â°F and 46Â°F). Do not freeze. Protect from light, keep in package until use.
</paragraph>
                     </text>
                     <effectiveTime value="20250418"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="s39">
               <id root="ee781e10-7658-4acc-a8fc-13d1bd0d7891"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
               <title>17 PATIENT COUNSELING INFORMATION
</title>
               <text>
                  <paragraph>Advise patients to consult their eye care professional, if pain, redness, or itching develops.
</paragraph>
                  <paragraph>Ocular Therapeutix, Inc.<br/>Bedford, MA 01730 USA
</paragraph>
                  <paragraph>US Patent Nos.: 8,409,606; 8,563,027, 11,458041, 12,144,889, 12,150,896
</paragraph>
               </text>
               <effectiveTime value="20250418"/>
            </section>
         </component>
         <component>
            <section ID="s40">
               <id root="77020761-2776-45a0-a07d-24846828c087"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Principal Display Panel â Dextenza 1 ct Box Label</content>
                  </paragraph>
                  <paragraph>NDC 70382-204-01
</paragraph>
                  <paragraph>
                     <content styleCode="bold">0.4 mg insert</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">1 insert</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Dextenza
</content>
                     <content styleCode="bold">
                        <sup>Â®</sup>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">(dexamethasone ophthalmic insert) 0.4mg</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">for intracanalicular use</content>
                  </paragraph>
                  <paragraph>Rx only
</paragraph>
                  <paragraph>
                     <content styleCode="bold italics">Ocular</content>
                  </paragraph>
                  <paragraph>Therapeutixâ¢
</paragraph>
                  <renderMultiMedia ID="f02" referencedObject="mm02"/>
               </text>
               <effectiveTime value="20250418"/>
               <component>
                  <observationMedia ID="mm02">
                     <text>Principal Display Panel â Dextenza 1 ct Box Label
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dex0e-0020-02.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="s41">
               <id root="567a120d-b461-4a4b-bc74-1a526ebebde8"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Principal Display Panel â Dextenza 10 ct Box Label</content>
                  </paragraph>
                  <paragraph>NDC 70382-204-10
</paragraph>
                  <paragraph>
                     <content styleCode="bold">0.4 mg insert</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">10 inserts</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Dextenza
</content>
                     <content styleCode="bold">
                        <sup>Â®</sup>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">(dexamethasone ophthalmic insert) 0.4mg</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">for intracanalicular use</content>
                  </paragraph>
                  <paragraph>Rx only
</paragraph>
                  <paragraph>
                     <content styleCode="bold italics">Ocular</content>
                  </paragraph>
                  <paragraph>Therapeutixâ¢
</paragraph>
                  <renderMultiMedia ID="f03" referencedObject="mm03"/>
               </text>
               <effectiveTime value="20250418"/>
               <component>
                  <observationMedia ID="mm03">
                     <text>Principal Display Panel â Dextenza 10 ct Box Label
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dex0e-0020-03.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="s42">
               <id root="6c5e2740-5f55-46d7-9c5c-65932f07aa58"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Principal Display Panel â Dextenza Sample 1 ct Box Label</content>
                  </paragraph>
                  <paragraph>NDC 70382-204-99
</paragraph>
                  <paragraph>
                     <content styleCode="bold">0.4 mg insert</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">1 inserts</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Dextenza
</content>
                     <content styleCode="bold">
                        <sup>Â®</sup>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">(dexamethasone ophthalmic insert) 0.4mg</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">for intracanalicular use</content>
                  </paragraph>
                  <paragraph>Rx only
</paragraph>
                  <paragraph>
                     <content styleCode="bold">SAMPLE</content>
                  </paragraph>
                  <paragraph>Not for resale.
</paragraph>
                  <paragraph>US Patent Nos.
</paragraph>
                  <paragraph>7,648,713 8,409,606 8,563,027 9,254,267
</paragraph>
                  <paragraph>
                     <content styleCode="bold italics">Ocular</content>
                  </paragraph>
                  <paragraph>Therapeutixâ¢
</paragraph>
                  <renderMultiMedia ID="f04" referencedObject="mm04"/>
               </text>
               <effectiveTime value="20250418"/>
               <component>
                  <observationMedia ID="mm04">
                     <text>Principal Display Panel â Dextenza Sample 1 ct Box Label
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dex0e-0020-04.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="s43">
               <id root="d61842eb-9270-4eaa-9888-f605fd43b6fa"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Principal Display Panel â Dextenza Pouch Label</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Dextenza
</content>
                     <content styleCode="bold">
                        <sup>Â®</sup>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">(dexamethasone ophthalmic insert) 0.4mg</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">for intracanalicular use</content>
                  </paragraph>
                  <paragraph>Ocular Therapeutix, Inc.
</paragraph>
                  <paragraph>Bedford, MA 01730 USA
</paragraph>
                  <paragraph>NDC 70382-204-88
</paragraph>
                  <paragraph>Rx only
</paragraph>
                  <paragraph>
                     <content styleCode="bold">LOT:</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">EXP DATE:</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">DIRECTIONS FOR USE:</content> See enclosed package<br/>insert. Do not use if pouch has been damaged<br/>or broken. DEXTENZA is intended for single dose only.
</paragraph>
                  <paragraph>
                     <content styleCode="bold">CONTENTS:</content> One DEXTENZA insert in foam carrier.
</paragraph>
                  <paragraph>
                     <content styleCode="bold">STORAGE:</content> Refrigerate between 2 Â° C - 8 Â° C<br/>(36Â° F - 46Â° F). Do not freeze. Protect from light,<br/>keep in package until use.
</paragraph>
                  <paragraph>
                     <content styleCode="bold">STERILE:</content> Do not re-sterilize.
</paragraph>
                  <paragraph>PCR-780-12173
</paragraph>
                  <renderMultiMedia ID="f05" referencedObject="mm05"/>
               </text>
               <effectiveTime value="20250418"/>
               <component>
                  <observationMedia ID="mm05">
                     <text>Principal Display Panel â Dextenza Pouch Label
</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="dex0e-0020-05.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>